DRKS00027573招募中未知
HepaLipa-Study: Observing the influence of an IL-17 inhibition on liver steatosis and inflammation. - HepaLipa
niversitätsklinikum Freiburg, Department Innere Medizin0 个研究点目标入组 160 人开始时间: 2022年1月14日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 160
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomized controlled study
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •Patients with an existing indication for drug therapy of psoriasis, psoriatic arthritis or ankylosing spondylitis.
排除标准
- •other liver diseases (ethyl toxic, viral, secondary), acutely life-threatening diseases, pregnant women, known drug abuse or participation in a drug substitution program, inability to give consent
研究者
相似试验
进行中（未招募）
1 期
Investigation of the effect of Interleukin-1 receptor antagonist (IL-1ra) on markers of inflammation in non-ST elevation acute coronary syndromes - MRC-ILA-HEART studyWe wish to investigate Acute coronary syndromes (ACS). These are caused by blockages in the main arteries that supply the heart as a result of a process called atherosclerosis. These blockages prevent blood flow down the artery and therefore prevent the heart muscle getting the blood and oxygen that it needs to survive and function. They account for 15% of all deaths in the UK and are associated with considerable long term consequences among survivors.MedDRA version: 8.1 Level: PT Classification code 10051592 Term: Acute coronary syndromeEUCTR2006-001767-31-GBniversity of Sheffield186
已完成
不适用
Investigation of the effect of InterLeukin-1 receptor Antagonist on markers of inflammation in non-ST elevation acute coronary syndromeson-ST elevation acute coronary syndromesCirculatory SystemCoronary syndromesISRCTN89369318niversity of Sheffield (UK)186
已完成
1 期
An open-label study of the cerebrospinal fluid pharmacokinetics of intravenous Kineret® (recombinant methyionyl human interleukin-1 receptor antagonist [r-metHuIL-1RA]) in patients with subarachnoid haemorrhageISRCTN45931429Salford Royal Foundation Hospital Trust (UK)100
已完成
不适用
effect of periodontal treatment on IL-17 and IL-23IRCT20180729040623N1Shahed University36
进行中（未招募）
不适用
Blocking the inflammation-factor IL-1 as treatment for degenerative joint disease of the handsosteoarthritis of the handEUCTR2012-004089-16-ATniversitätsklinik für Innere Medizin III, Klinische Abteilung für Rheumatologie, Medizinische Universität Wien